Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)

HPV VLPs as Scaffolds for Vaccine Design

(2019) Thomas Jordan et al.   BIOPHYSICAL JOURNAL

Virus‐like particles for vaccination against cancer

(2019) Mona O. Mohsen et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity

(2019) Aleyo Chabeda et al.   Frontiers in Plant Science

A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs

(2018) Annebel R. De Vleeschauwer et al.   VACCINE

Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana

(2018) Varusha Pillay Veerapen et al.   VIRUS RESEARCH

A call for the introduction of gender-neutral HPV vaccination to national immunisation programmes in Africa

(2018) Onyema Greg Chido-Amajuoyi et al.   Lancet Global Health

The global burden of women’s cancers: a grand challenge in global health

(2017) Ophira Ginsburg et al.   LANCET

Molecular pharming — VLPs made in plants

(2016) Johanna Marsian et al.   CURRENT OPINION IN BIOTECHNOLOGY

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

(2016) Laia Bruni et al.   Lancet Global Health

Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves

(2016) Maryam Zahin et al.   PLoS One

Recent progress in vaccination against human papillomavirus-mediated cervical cancer

(2015) Sara J. McKee et al.   REVIEWS IN MEDICAL VIROLOGY

Identification, Characterization and Down-Regulation of Cysteine Protease Genes in Tobacco for Use in Recombinant Protein Production

(2015) Kishor Duwadi et al.   PLoS One

Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras

(2013) Catherine B. Pineo et al.   PLANT BIOTECHNOLOGY JOURNAL

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy

(2013) Qinjian Zhao et al.   Human Vaccines & Immunotherapeutics

Plant-derived virus-like particles as vaccines

(2012) Qiang Chen et al.   Human Vaccines & Immunotherapeutics

GMP issues for recombinant plant-derived pharmaceutical proteins

(2011) Rainer Fischer et al.   BIOTECHNOLOGY ADVANCES

A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection

(2011) S. Longet et al.   JOURNAL OF VIROLOGY

Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

(2010) Mark H. Einstein et al.   Human vaccines & immunotherapeutics

Plant-made vaccines for humans and animals

(2010) Edward P. Rybicki   PLANT BIOTECHNOLOGY JOURNAL

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types

(2009) Rolando Herrero   JOURNAL OF INFECTIOUS DISEASES

One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae

(2009) Hyoung Jin Kim et al.   PROTEIN EXPRESSION AND PURIFICATION

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice

(2009) Georgina De la Rosa et al.   Virology Journal

Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic

(2008) Alicia Fernández-San Millán et al.   PLANT BIOTECHNOLOGY JOURNAL

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

(2008) John T. Schiller et al.   VACCINE